Eton Pharmaceuticals Ownership | Who Owns Eton Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Eton Pharmaceuticals Ownership Summary


Eton Pharmaceuticals is owned by 12.61% institutional investors, 5.39% insiders, and 82.00% retail investors. Opaleye management is the largest institutional shareholder, holding 11.01% of ETON shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.55% of its assets in Eton Pharmaceuticals shares.

ETON Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEton Pharmaceuticals12.61%5.39%82.00%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Opaleye management2.85M11.01%$37.99M
Ecor1 capital1.83M7.06%$24.37M
Nantahala capital management1.12M4.32%$14.90M
Vanguard group1.06M4.11%$14.17M
Westside investment management575.22K2.22%$7.66M
Cannell capital381.32K1.47%$5.08M
Blackrock funding, inc. /de317.63K1.23%$4.23M
Paradigm capital management inc/ny300.00K1.16%$987.00K
Blackrock282.39K1.10%$929.06K
Parkman healthcare partners276.89K1.07%$3.69M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Opaleye management2.85M6.65%$37.99M
Acuitas investments185.82K2.03%$2.48M
Westside investment management575.22K1.61%$7.66M
Cannell capital381.32K1.04%$5.08M
Ecor1 capital1.83M0.92%$24.37M
Aristides capital241.59K0.66%$3.22M
Nantahala capital management1.12M0.64%$14.90M
Parkman healthcare partners276.89K0.49%$3.69M
Eam investors95.02K0.18%$1.27M
Bridgeway capital management238.96K0.07%$3.18M

Top Buyers

HolderShares% AssetsChange
Ecor1 capital1.83M0.92%1.26M
Cannell capital381.32K1.04%381.32K
Connor, clark & lunn investment management214.88K0.01%149.86K
Acadian asset management248.50K0.01%142.55K
Millennium management138.89K0.00%138.89K

Top Sellers

HolderShares% AssetsChange
Acuitas investments185.82K2.03%-394.14K
Stonepine capital management---110.00K
Westside investment management575.22K1.61%-43.45K
Squarepoint ops---41.26K
Eam investors95.02K0.18%-33.26K

New Positions

HolderShares% AssetsChangeValue
Cannell capital381.32K1.04%381.32K$5.08M
Millennium management138.89K0.00%138.89K$1.85M
683 capital management69.00K0.06%69.00K$919.08K
Anchor capital advisors60.43K0.02%60.43K$804.95K
Barclays54.89K0.00%54.89K$731.00K

Sold Out

HolderChange
Lindbrook capital-4.00
Group one trading-722.00
Plante moran financial advisors-1.00K
Adar1 capital management-1.20K
Occudo quantitative strategies lp-12.17K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202424-52.94%3,267,082-65.64%120.94%14-46.15%6-
Sep 30, 2024518.51%9,507,91415.55%363.60%2685.71%6-60.00%
Jun 30, 2024474.44%8,228,30814.56%314.09%14-1515.38%
Mar 31, 202445-22.41%7,182,6880.34%273.60%14-54.84%1330.00%
Dec 31, 2023589.43%7,158,4113.75%273.83%31-6.06%1066.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv681.72K2.55%-
Vanguard US Total Market Shares ETF681.72K2.54%-
Vanguard Institutional Extnd Mkt Idx Tr367.85K1.38%5.42K
Paradigm Micro-Cap200.00K0.77%-
Bridgeway Ultra-Small Company168.76K0.65%-10.00K
Fidelity Extended Market Index133.91K0.50%-853.00
Wasatch Micro Cap Value105.10K0.40%-
IMC US Ultra Micro Cap95.02K0.36%-33.26K
EAM Ultra Micro Cap95.02K0.36%-33.26K
Vifag 2002 SICAV90.00K0.35%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 23, 2024Opaleye Management Inc.-Buy$79.81K
Oct 08, 2024Opaleye Management Inc.-Buy$27.91K
Oct 08, 2024Opaleye Management Inc.-Buy$210.88K
Oct 07, 2024Opaleye Management Inc.-Buy$72.23K
Oct 04, 2024Opaleye Management Inc.-Buy$101.56K

Insider Transactions Trends


DateBuySell
2024 Q47-
2024 Q34-
2024 Q1--
2023 Q1--
2022 Q31-

ETON Ownership FAQ


Who Owns Eton Pharmaceuticals?

Eton Pharmaceuticals shareholders are primarily institutional investors at 12.61%, followed by 5.39% insiders and 82.00% retail investors. The average institutional ownership in Eton Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Eton Pharmaceuticals falls below.

Who owns the most shares of Eton Pharmaceuticals?

Eton Pharmaceuticals’s largest shareholders are Opaleye management (2.85M shares, 11.01%), Ecor1 capital (1.83M shares, 7.06%), and Nantahala capital management (1.12M shares, 4.32%). Together, they hold 22.39% of Eton Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eton Pharmaceuticals?

Yes, BlackRock owns 1.10% of Eton Pharmaceuticals, totaling 282.39K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 929.06K$. In the last quarter, BlackRock decreased its holdings by -563 shares, a -0.20% change.

Who is Eton Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Opaleye management is Eton Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 6.65% of its assets in 2.85M Eton Pharmaceuticals shares, valued at 37.99M$.

Who is the top mutual fund holder of Eton Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eton Pharmaceuticals shares, with 2.55% of its total shares outstanding invested in 681.72K Eton Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools